Research and Markets (http://www.researchandmarkets.com/research/2tvv3j/fistulapipeline) has announced the addition of the "Fistula-Pipeline Insights, 2014" subscription to their offering.
This Fistula-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fistula.
This report provides information on the therapeutic development based on the Fistula dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND Filed, Pre-Clinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule-type drug information.
The report also covers the companies' information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Fistula Overview
- Fistula Pipeline Therapeutics
- Fistula Therapeutics under Development by Companies
- Fistula Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Fistula Mid-Clinical Stage Products (Phase II)
- Comparative Analysis
- Fistula Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Fistula Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Fistula - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Fistula - Discontinued Products
- Fistula - Dormant Products
- Companies Involved in Therapeutics Development for Fistula
- Appendix
For more information visit http://www.researchandmarkets.com/research/2tvv3j/fistulapipeline.